The regeneration and transplantation of islet β cells and the reconstruction of insulin secretion function have become new strategies for curing diabetes, but the donor and site of transplantation and the selection of transplantation carriers are the key to this strategy. This evidence concerns the gene INS and diabetes mellitus.